Chinook Therapeutics Inc
NASDAQ:KDNY
Income Statement
Earnings Waterfall
Chinook Therapeutics Inc
Revenue
|
5.8m
USD
|
Operating Expenses
|
-257.5m
USD
|
Operating Income
|
-251.6m
USD
|
Other Expenses
|
6m
USD
|
Net Income
|
-245.7m
USD
|
Income Statement
Chinook Therapeutics Inc
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||
Revenue |
4
N/A
|
13
+253%
|
23
+71%
|
32
+39%
|
48
+52%
|
73
+51%
|
67
-8%
|
97
+43%
|
81
-16%
|
51
-38%
|
50
-1%
|
17
-66%
|
17
N/A
|
17
-1%
|
20
+17%
|
17
-16%
|
16
-4%
|
15
-6%
|
12
-18%
|
15
+18%
|
16
+12%
|
17
+5%
|
27
+58%
|
28
+2%
|
27
-4%
|
1
-97%
|
(13)
N/A
|
(18)
-43%
|
(22)
-21%
|
52
N/A
|
54
+5%
|
54
+1%
|
57
+5%
|
6
-89%
|
5
-14%
|
6
+11%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||
Operating Expenses |
(26)
|
(33)
|
(40)
|
(55)
|
(66)
|
(87)
|
(100)
|
(116)
|
(125)
|
(123)
|
(121)
|
(116)
|
(121)
|
(124)
|
(124)
|
(123)
|
(118)
|
(112)
|
(116)
|
(107)
|
(104)
|
(101)
|
(96)
|
(93)
|
(86)
|
(56)
|
(67)
|
(97)
|
(111)
|
(158)
|
(147)
|
(140)
|
(170)
|
(191)
|
(221)
|
(257)
|
|
Selling, General & Administrative |
(7)
|
(9)
|
(14)
|
(18)
|
(23)
|
(28)
|
(31)
|
(33)
|
(35)
|
(34)
|
(34)
|
(33)
|
(33)
|
(34)
|
(35)
|
(35)
|
(36)
|
(36)
|
(36)
|
(35)
|
(35)
|
(35)
|
(33)
|
(35)
|
(34)
|
(19)
|
(21)
|
(19)
|
(19)
|
(32)
|
(30)
|
(31)
|
(34)
|
(36)
|
(40)
|
(44)
|
|
Research & Development |
(19)
|
(24)
|
(29)
|
(38)
|
(44)
|
(59)
|
(69)
|
(82)
|
(90)
|
(88)
|
(87)
|
(82)
|
(87)
|
(89)
|
(89)
|
(87)
|
(81)
|
(76)
|
(75)
|
(72)
|
(68)
|
(66)
|
(62)
|
(58)
|
(51)
|
(36)
|
(46)
|
(58)
|
(72)
|
(97)
|
(98)
|
(105)
|
(123)
|
(141)
|
(166)
|
(194)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Other Operating Expenses |
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20)
|
(20)
|
(27)
|
(17)
|
(3)
|
(10)
|
(12)
|
(14)
|
(18)
|
|
Operating Income |
(22)
N/A
|
(19)
+14%
|
(17)
+12%
|
(23)
-39%
|
(18)
+25%
|
(14)
+23%
|
(32)
-138%
|
(20)
+40%
|
(44)
-125%
|
(72)
-64%
|
(71)
+1%
|
(98)
-38%
|
(104)
-5%
|
(106)
-3%
|
(104)
+2%
|
(106)
-2%
|
(101)
+4%
|
(97)
+4%
|
(104)
-6%
|
(93)
+10%
|
(87)
+6%
|
(84)
+4%
|
(69)
+18%
|
(65)
+6%
|
(59)
+10%
|
(55)
+7%
|
(80)
-47%
|
(116)
-44%
|
(134)
-15%
|
(106)
+20%
|
(93)
+13%
|
(86)
+7%
|
(113)
-31%
|
(185)
-64%
|
(216)
-17%
|
(252)
-17%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(3)
|
(2)
|
(1)
|
(0)
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
5
|
5
|
5
|
6
|
6
|
6
|
5
|
5
|
4
|
3
|
(0)
|
0
|
0
|
(2)
|
(2)
|
(2)
|
(4)
|
(4)
|
(3)
|
(4)
|
(1)
|
|
Non-Reccuring Items |
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
(5)
|
(10)
|
(6)
|
(11)
|
(11)
|
(8)
|
(29)
|
(27)
|
(17)
|
(16)
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
1
|
1
|
(8)
|
(25)
|
(26)
|
(26)
|
(17)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
1
|
2
|
5
|
8
|
11
|
|
Pre-Tax Income |
(21)
N/A
|
(17)
+20%
|
(26)
-52%
|
(48)
-88%
|
(43)
+11%
|
(39)
+9%
|
(48)
-23%
|
(18)
+62%
|
(42)
-131%
|
(70)
-65%
|
(69)
+1%
|
(96)
-39%
|
(101)
-5%
|
(103)
-3%
|
(100)
+3%
|
(101)
-1%
|
(97)
+5%
|
(96)
+0%
|
(98)
-2%
|
(92)
+6%
|
(92)
+0%
|
(85)
+8%
|
(75)
+12%
|
(73)
+3%
|
(64)
+12%
|
(84)
-30%
|
(108)
-29%
|
(134)
-25%
|
(151)
-12%
|
(101)
+33%
|
(95)
+5%
|
(90)
+6%
|
(114)
-28%
|
(184)
-60%
|
(212)
-16%
|
(241)
-14%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(5)
|
(16)
|
(21)
|
(15)
|
(10)
|
5
|
15
|
12
|
8
|
5
|
1
|
1
|
1
|
3
|
2
|
8
|
8
|
6
|
2
|
0
|
(3)
|
(3)
|
(2)
|
0
|
(3)
|
(3)
|
(4)
|
0
|
0
|
|
Income from Continuing Operations |
(21)
|
(17)
|
(26)
|
(48)
|
(43)
|
(39)
|
(51)
|
(23)
|
(58)
|
(91)
|
(84)
|
(106)
|
(95)
|
(88)
|
(88)
|
(93)
|
(92)
|
(95)
|
(97)
|
(91)
|
(89)
|
(82)
|
(67)
|
(65)
|
(58)
|
(82)
|
(111)
|
(137)
|
(153)
|
(103)
|
(97)
|
(92)
|
(118)
|
(188)
|
(216)
|
(246)
|
|
Net Income (Common) |
(21)
N/A
|
(17)
+20%
|
(26)
-52%
|
(48)
-88%
|
(43)
+11%
|
(39)
+9%
|
(51)
-31%
|
(23)
+56%
|
(58)
-156%
|
(91)
-56%
|
(84)
+8%
|
(106)
-26%
|
(95)
+10%
|
(92)
+4%
|
(92)
+0%
|
(97)
-5%
|
(95)
+1%
|
(95)
0%
|
(97)
-2%
|
(91)
+6%
|
(89)
+2%
|
(82)
+8%
|
(67)
+19%
|
(65)
+3%
|
(58)
+10%
|
(82)
-40%
|
(111)
-36%
|
(137)
-23%
|
(153)
-12%
|
(103)
+33%
|
(97)
+5%
|
(92)
+5%
|
(118)
-27%
|
(188)
-60%
|
(216)
-15%
|
(246)
-14%
|
|
EPS (Diluted) |
-1.71
N/A
|
-1.37
+20%
|
-2.07
-51%
|
-4.6
-122%
|
-3.01
+35%
|
-4.39
-46%
|
-4.02
+8%
|
-1.59
+60%
|
-4.48
-182%
|
-6.99
-56%
|
-6.16
+12%
|
-7.44
-21%
|
-6.34
+15%
|
-6.3
+1%
|
-5.87
+7%
|
-6.12
-4%
|
-6.01
+2%
|
-6.05
-1%
|
-6.1
-1%
|
-5.71
+6%
|
-5.56
+3%
|
-5.14
+8%
|
-4.11
+20%
|
-4.01
+2%
|
-3.6
+10%
|
-6.2
-72%
|
-2.64
+57%
|
-3.12
-18%
|
-3.43
-10%
|
-2.26
+34%
|
-1.66
+27%
|
-1.49
+10%
|
-1.73
-16%
|
-2.92
-69%
|
-3.06
-5%
|
-3.43
-12%
|